A detailed history of Promethium Advisors,Llc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Promethium Advisors,Llc holds 56,050 shares of BMY stock, worth $3.37 Million. This represents 2.17% of its overall portfolio holdings.

Number of Shares
56,050
Previous 69,550 19.41%
Holding current value
$3.37 Million
Previous $3.6 Billion 11.9%
% of portfolio
2.17%
Previous 2.54%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$51.92 - $59.94 $700,920 - $809,190
-13,500 Reduced 19.41%
56,050 $3.17 Billion
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $2.76 Million - $3.6 Million
69,550 New
69,550 $3.6 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $128B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Promethium Advisors,Llc Portfolio

Follow Promethium Advisors,Llc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Promethium Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Promethium Advisors,Llc with notifications on news.